Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Sage Therapeutics, Inc. | SVP, GC & Secretary | Common Stock | 24K | $215K | $8.96 | Aug 5, 2024 | Direct |
Sage Therapeutics, Inc. | SVP, GC & Secretary | Stock Option (Right to Buy) | 22.5K | Feb 13, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
SAGE | Sage Therapeutics, Inc. | Aug 5, 2024 | 2 | -$40.3K | 4 | Aug 7, 2024 | SVP, GC & Secretary |
SAGE | Sage Therapeutics, Inc. | Feb 13, 2024 | 2 | $0 | 4 | Feb 15, 2024 | SVP, GC & Secretary |
SAGE | Sage Therapeutics, Inc. | Nov 28, 2023 | 2 | -$22.6K | 4 | Nov 30, 2023 | SVP, GC & Secretary |
SAGE | Sage Therapeutics, Inc. | Feb 13, 2023 | 1 | $0 | 4 | Feb 15, 2023 | SVP, GC & Secretary |
SAGE | Sage Therapeutics, Inc. | Feb 3, 2023 | 2 | -$43.3K | 4 | Feb 7, 2023 | SVP, GC & Secretary |
SAGE | Sage Therapeutics, Inc. | Feb 11, 2022 | 1 | $0 | 4 | Feb 15, 2022 | SVP, GC & Secretary |
SAGE | Sage Therapeutics, Inc. | Oct 19, 2021 | 2 | -$45K | 4 | Oct 21, 2021 | SVP, GC & Secretary |
SAGE | Sage Therapeutics, Inc. | Jun 15, 2021 | 2 | -$67.3K | 4 | Jun 17, 2021 | SVP, GC & Secretary |